0000899243-22-014873.txt : 20220415 0000899243-22-014873.hdr.sgml : 20220415 20220415160526 ACCESSION NUMBER: 0000899243-22-014873 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220408 FILED AS OF DATE: 20220415 DATE AS OF CHANGE: 20220415 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mitrano Richard J. CENTRAL INDEX KEY: 0001785287 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39062 FILM NUMBER: 22830090 MAIL ADDRESS: STREET 1: C/O FREQUENCY THERAPEUTICS, INC. STREET 2: 19 PRESIDENTIAL WAY, 2ND FLOOR CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Frequency Therapeutics, Inc. CENTRAL INDEX KEY: 0001703647 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 472324450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-315-4600 MAIL ADDRESS: STREET 1: 75 HAYDEN AVENUE STREET 2: SUITE 300 CITY: LEXINGTON STATE: MA ZIP: 02421 3 1 doc3.xml FORM 3 SUBMISSION X0206 3 2022-04-08 0 0001703647 Frequency Therapeutics, Inc. FREQ 0001785287 Mitrano Richard J. C/O FREQUENCY THERAPEUTICS, INC., 75 HAYDEN AVENUE LEXINGTON MA 02421 0 1 0 0 VP, Finance Common Stock 25679 D Common Stock 4032 I Held by The Carey/Mitrano Family Trust Restricted Stock Units 0.00 2023-07-04 Common Stock 25000 D Restricted Stock Units 0.00 2022-07-04 Common Stock 7500 D Stock Option (Right to Buy) 35.85 2031-01-14 Common Stock 11550 D Stock Option (Right to Buy) 25.05 2030-02-11 Common Stock 18000 D Stock Option (Right to Buy) 14.00 2029-10-01 Common Stock 17816 D Stock Option (Right to Buy) 3.37 2029-04-16 Common Stock 28805 D Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2021, and will be fully vested and exercisable on January 1, 2025. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2020, and will be fully vested and exercisable on January 1, 2024. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on November 2, 2019, and will be fully vested and exercisable on October 2, 2023. The option vests and becomes exercisable in equal monthly installments over a four year period commencing on February 1, 2019, and will be fully vested and exercisable on January 1, 2023. Exhibit 24 - Power of Attorney. /s/ James P. Abely, Attorney-in-Fact 2022-04-15 EX-24 2 attachment1.htm EX-24 DOCUMENT
                                                                   Exhibit 24

                                POWER OF ATTORNEY

        With respect to holdings of and transactions in securities issued by
Frequency Therapeutics, Inc. (the "Company"), the undersigned hereby
constitutes and appoints the individuals named on Schedule A attached hereto
and as may be amended from time to time, or any of them signing singly, with
full power of substitution and resubstitution, to act as the undersigned's true
and lawful attorney-in-fact to:

        1.  prepare, execute in the undersigned's name and on the
        undersigned's behalf, and submit to the United States Securities and
        Exchange Commission (the "SEC") a Form ID, including amendments
        thereto, and any other documents necessary or appropriate to obtain
        and/or regenerate codes and passwords enabling the undersigned to make
        electronic filings with the SEC of reports required by Section 16(a) of
        the Securities Exchange Act of 1934, as amended, or any rule or
        regulation of the SEC;

        2.  execute for and on behalf of the undersigned, Forms 3, 4, and 5
        in accordance with Section 16 of the Securities Exchange Act of 1934,
        as amended, and the rules thereunder;

        3.  do and perform any and all acts for and on behalf of the
        undersigned which may be necessary or desirable to complete and execute
        any such Form 3, 4, or 5, complete and execute any amendment or
        amendments thereto, and timely file such form with the SEC and any
        stock exchange or similar authority; and

        4.    take any other action of any type whatsoever in connection with
        the foregoing which, in the opinion of such attorney-in-fact, may be of
        benefit to, in the best interest of, or legally required by, the
        undersigned, it being understood that the documents executed by such
        attorney-in-fact on behalf of the undersigned pursuant to this Power of
        Attorney shall be in such form and shall contain such terms and
        conditions as such attorney-in-fact may approve in such attorney-in-
        fact's discretion.

        The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the rights
and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution and resubstitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorneys-in-fact substitute or
substitutes, shall lawfully do or cause to be done by virtue of this Power of
Attorney and the rights and powers herein granted.

        The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934, as amended.

        This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

        IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 12th day of September, 2019.


                                   Signature:  /s/ Richard Mitrano
                                               -------------------
                                   Print Name: Richard Mitrano


                                Schedule A

        Individuals Appointed as Attorney-in-Fact with Full Power of
Substitution and Resubstitution

David L. Lucchino
James P. Abely